Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1996-8-29
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1165-1083
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
184-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8688899-Estrogen Replacement Therapy,
pubmed-meshheading:8688899-Ethics, Medical,
pubmed-meshheading:8688899-Female,
pubmed-meshheading:8688899-Humans,
pubmed-meshheading:8688899-Informed Consent,
pubmed-meshheading:8688899-Neoplasms,
pubmed-meshheading:8688899-Patient Education as Topic
|
pubmed:year |
1996
|
pubmed:articleTitle |
[Should patients be informed of potential but not confirmed risks of cancer linked to menopausal hormone replacement treatment?].
|
pubmed:publicationType |
Journal Article
|